Depression isn’t a personal failing, it’s a brain that can’t regulate itself. TMS therapy targets the neural circuits driving mood dysregulation, rebuilding function without medication side effects.
Major Depressive Disorder is rooted in dysregulation between the prefrontal cortex (your mood regulator), the limbic system (your emotional core), and the default mode network. When these circuits fall out of sync, the brain defaults to a state of persistent negativity, exhaustion, and emotional numbness.
Traditional treatments address symptoms. TMS targets the source — restoring healthy neural activity in the circuits that govern mood, motivation, and reward.
Transcranial Magnetic Stimulation uses precisely targeted magnetic pulses to modulate the brain circuits responsible for mood regulation and emotional processing.
TMS coils target the left dorsolateral prefrontal cortex (DLPFC) — the region most consistently underactive in depression. Stimulating this area restores top-down regulation of mood and emotional response.
High-frequency TMS pulses increase activity in hypoactive circuits, while deep TMS can engage the subgenual cingulate — a key node in the depression network — reducing its overactive rumination signal.
Over the course of treatment, repeated stimulation strengthens healthier neural pathways. The brain learns to regulate mood more effectively, producing change that extends well beyond the treatment window.
From your first consultation to lasting relief, here’s exactly what the Continuum TMS experience looks like.
TMS for anxiety is backed by a growing body of clinical evidence — not just anecdote.
of patients achieve response (meaningful symptom reduction) with TMS for MDD
systemic side effects — no weight gain, no sedation, no sexual dysfunction
minutes per session — no downtime, return to your day immediately
cleared TMS technology with proven safety record since 2008
For many people with depression, antidepressants offer partial relief or come with side effects that make them difficult to sustain. For treatment-resistant depression, TMS offers a fundamentally different approach — working directly at the level of brain circuitry rather than altering neurochemistry.
Multiple randomised controlled trials demonstrate TMS’s effectiveness for MDD, with remission rates significantly exceeding placebo in patients who have not responded to prior medications.
“TMS has demonstrated clinically meaningful efficacy in major depressive disorder, offering a compelling alternative for patients with inadequate response to pharmacotherapy.” — Peer-reviewed clinical review, 2023
